Wright Investors Service’s Regeneron Pharmaceuticals REGN Stock Holding History

Wright Investors Service’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,515	Closed	-$2.22M	–	163
2021 Q4	$2.22M	Buy	3,515 +110	+3%	+$67.6K	0.56%	63
2021 Q3	$2.06M	Buy	+3,405	New	+$2.11M	0.59%	60
2021 Q1	–	Sell	-755	Closed	-$365K	–	163
2020 Q4	$365K	Buy	+755	New	+$408K	0.13%	136

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wright Investors Service's REGN Position: Q1 2022 in Review

Wright Investors Service sold out of Regeneron Pharmaceuticals (REGN) in Q1 2022, closing a stake of 3,515 shares — an estimated $2.22M sold.

Wright Investors Service first reported a position in REGN in Q4 2020 and held it in 3 quarters. The position peaked at $2.22M in Q4 2021. 1,095 funds tracked by Wall St. Rank hold REGN as of Q1 2022.

Wright Investors Service reported no remaining Regeneron Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Wright Investors Service sold 3,515 Regeneron Pharmaceuticals shares in Q1 2022, an estimated $2.22M.
Wright Investors Service first reported a position in Regeneron Pharmaceuticals in Q4 2020 and held it in 3 quarters.
Wright Investors Service's Regeneron Pharmaceuticals position peaked at $2.22M in Q4 2021.
1,095 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2022.

Based on Wright Investors Service's 13F filing for Q1 2022, filed 22 Apr 2022.